COVID-19住院患者中的脑静脉血栓形成:纽约都会区队列研究
作者建议将脑静脉血栓形成纳入SARS-CoV-2感染相关神经综合征的鉴别诊断。
要点
- COVID-19住院患者脑静脉血栓形成发生率为每万例8.8,明显高于普通人群。
- 58%的病例神经症状在呼吸及全身症状出现24小时内发生,75%有静脉梗死和/或出血。
- 脑静脉血栓形成应纳入COVID-19相关神经综合征的鉴别诊断。
核心结论
- 早期证据提示COVID-19住院患者中脑静脉血栓形成的发生率高于预期,应纳入SARS-CoV-2感染相关神经综合征的鉴别诊断。
研究设计与样本
- 回顾性多中心队列研究,纳入2020年3月1日至5月30日纽约都会区6家三级中心连续住院的13500例COVID-19患者。
- 以影像证实的脑静脉血栓形成为主要观察指标,分析人口学与临床特征。
关键影像表现/征象
- 男性多见(8男4女),平均年龄49岁(95% CI, 36-62岁;范围17-95岁)。
- 仅1例(8%)有血栓栓塞性疾病史。
- 58%的病例神经症状在呼吸及全身症状出现24小时内发生。
- 75%的病例脑影像显示静脉梗死、出血或两者兼有。
临床应用与阅片要点
- 对COVID-19患者出现神经症状时,即使缺乏传统血栓栓塞危险因素,也应警惕脑静脉血栓形成并考虑影像评估。
- 脑影像显示静脉梗死或出血时,应仔细评估静脉窦及皮质静脉以排查脑静脉血栓形成。
局限性
- 回顾性研究设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) infection is associated with hypercoagulability. We sought to evaluate the demographic and clinical characteristics of cerebral venous thrombosis among patients hospitalized for coronavirus disease 2019 (COVID-19) at 6 tertiary care centers in the New York City metropolitan area.
MATERIALS AND METHODS: We conducted a retrospective multicenter cohort study of 13,500 consecutive patients with COVID-19 who were hospitalized between March 1 and May 30, 2020.
RESULTS: Of 13,500 patients with COVID-19, twelve had imaging-proved cerebral venous thrombosis with an incidence of 8.8 per 10,000 during 3 months, which is considerably higher than the reported incidence of cerebral venous thrombosis in the general population of 5 per million annually. There was a male preponderance (8 men, 4 women) and an average age of 49 years (95% CI, 36-62 years; range, 17-95 years). Only 1 patient (8%) had a history of thromboembolic disease. Neurologic symptoms secondary to cerebral venous thrombosis occurred within 24 hours of the onset of the respiratory and constitutional symptoms in 58% of cases, and 75% had venous infarction, hemorrhage, or both on brain imaging. Management consisted of anticoagulation, endovascular thrombectomy, and surgical hematoma evacuation. The mortality rate was 25%.
CONCLUSIONS: Early evidence suggests a higher-than-expected frequency of cerebral venous thrombosis among patients hospitalized for COVID-19. Cerebral venous thrombosis should be included in the differential diagnosis of neurologic syndromes associated with SARS-CoV-2 infection.
引用
- Al-Mufti F, Amuluru K, Sahni R, et al. Cerebral Venous Thrombosis in COVID-19: A New York Metropolitan Cohort Study. AJNR Am J Neuroradiol. 2021. PMID: 33888450. doi:10.3174/ajnr.A7134
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。